Human piebald trait is an autosomal dominant defect in melanocyte development characterized by patches of hypopigmented skin and hair. Although the molecular basis of piebaldism has been unclear, a phenotypically similar "dominant spotting" of mice is caused by mutations in the murine c-kit protooncogene. In this regard, one piebald case with a point mutation and another with a deletion of c-kit have been reported, although a polymorphism or the involvement of a closely linked gene could not be excluded. To confirm the hypothesis that piebaldism results from mutations in the human gene, c-kit exons were amplified by polymerase chain reaction from the DNA of 10 affected subjects and screened for nucleotide changes by single-stranded conformation polymorphism analysis. In one subject with a variant single-stranded conformation polymorphism pattern for the first exon encoding the kinase domain, DNA sequencing demonstrated a missense mutation (Glu'3 --Lys). This mutation is identical to the mouse W37 mutation which abolishes autophosphorylation of the protein product and causes more extensive depigmentation than "null" mutations. In accord with this "dominant negative" effect, the identical mutation in this human kindred is associated with unusually extensive depigmentation. Thus, the finding ofa piebald subject with a mutation that impairs receptor activity strongly implicates the c-kit gene in the molecular pathogenesis of this human developmental defect. (J. Clin. Invest. 1992.
Introduction
Human piebald trait is characterized by autosomal dominant inheritance, a white hair forelock, stable areas of hypopigmentation or "leukoderma" on the anterior trunk and extremities, and the absence of extracutaneous manifestations (1) . In contrast to other albino syndromes, the affected areas in piebaldism are devoid of melanocytes, presumably resulting from a failure of embryonic migration or proliferation by primitive melanoblasts. Although the nature of the molecular defect has been unclear, mice with a "dominant spotting" phenotype, which affects both skin and hair pigmentation in a pattern that is very similar to human piebaldism, have been shown to carry heterozygous mutations of the mouse c-kit gene (2, 3) . Moreover, cytogenetic data have implicated the long arm of chromosome 4, a region which includes the human c-kit gene (4) (5) (6) , in the pathogenesis of piebald trait in three children with large interstitial deletions and multiple congenital anomalies (7) .
In accord with the hypothesis that mutations ofthe human gene can cause piebald trait, a mutation in c-kit that is linked to the piebald phenotype in one kindred has been reported recently (8) . Although this amino acid substitution appears not to be a common polymorphism, a resultant alteration in receptor function has not been demonstrated. Similarly, we have recently described a cytogenetically normal piebald subject who carries a heterozygous deletion of the c-kit gene (9) . However, because this deletion extends beyond c-kit, the involvement of a closely linked gene could not be excluded.
To detect additional cases of piebald kindreds with c-kit mutations, we have used genomic polymerase chain reaction (PCR)' to amplify individual exons of the c-kit gene. To simplify the analysis, we focused initially on five exons which encode most of the tyrosine kinase domain. Previous data from studies of mouse c-kit mutations suggested that a high proportion of point mutations occur in this region (10, 1 1). Before cloning and sequencing, the PCR products were screened for nucleotide alterations by single-stranded conformation polymorphism (SSCP) analysis, a technique that can detect a high frequency of single nucleotide changes in DNA sequences < 400 bp in length (12) .
Using this methodology, we demonstrate that one piebald subject manifests a variant SSCP pattern for the first exon encoding the tyrosine kinase domain of c-kit. Cloning and sequencing of this DNA segment reveals a mutation that substitutes a lysine for a glutamic acid at position 583. Because the identical mutation has been shown to completely abolish receptor kinase activity in the entirely homologous ATP-binding domain of the mouse c-kit gene (10, 11) , these data strongly suggest that this mutation is the cause of piebaldism in this individual and that the c-kit receptor has a similar function in both human and mouse development.
Methods
Subjects. Seven piebald individuals (subjects A-G), each from unrelated kindreds, have been previously described (9) . One subject (B) has been shown to carry a germ-line heterozygous deletion ofthe c-kit gene, while Southern blots of the c-kit gene from the other six cases were normal. Three additional subjects with suggestive but not diagnostic features ofpiebald trait are included in the current study. Subject H is a Hispanic infant born with a very small white forelock, but no family history or leukoderma. Subject I is a black female with no leukoderma, a history of a white forelock for the first several years of life, and a similarly affected brother. The white forelock is now indistinguishable at eight years of age. Subject J is a mentally retarded white male with the fragile X syndrome who has been previously described (13, 14) . Although this individual and his father both have a prominent white forelock and leukoderma, the pattern of depigmentation includes the upper thoracic paravertebral areas, an atypical area for piebaldism (1) . None of the subjects has extracutaneous manifestations that would suggest the diagnosis of Waardenburgs syndrome, which also has pigmentary disturbances and maps to human chromosome 2 (15).
Oligonucleotide primers. In the absence of sequence data for the introns of human c-kit, the primer oligonucleotides were located within the exons at intron boundaries predicted by homology with the human c-fms gene (16) . To amplify the exons encoding the tyrosine kinase domains of c-kit, primers complementary to the human c-kit sequences (4) 
Results
Amplification of c-kit exons. Southern blot analyses failed to detect rearrangements of c-kit gene in the seven subjects previously described (9) or in the three additional subjects reported here (data not shown). One explanation for this result is that piebaldism frequently results from point mutations or small deletions/insertions that cannot be detected by Southern analysis. To identify such changes, genomic PCR was used to amplify five exons predicted to encode most of the tyrosine kinase domains ofc-kit. The sequences and locations ofthe oligonucleotide primers for these exons were derived by aligning the cDNA sequence of c-kit with the known intron-exon boundaries of human c-fms (16) . The sizes of the products amplified with these primers exactly parallels the published data for the homologous exons of human c-fms (data not shown). SSCP. To screen exons from the 10 subjects for mutations, the amplified DNA fragments were subjected to SSCP analysis. The patterns for DNA fragments homologous to c-fms exons 13-14 and 18-19 were identical in all 10 subjects (data not shown). However, for the fragment homologous to c-fins exon 12, one subject demonstrates a variant SSCP pattern (Fig. 1,  lane 3) . The major band at the top of the gel in all of the lanes corresponds to the renatured double-stranded PCR product. The two faster migrating bands are thought to represent the two single-stranded chains of the denatured PCR product. As shown in lane 3, two additional bands are present in this subject's DNA, suggesting the presence of an altered DNA sequence in one of the two alleles of this c-kit sequence.
DNA sequencing. To determine the basis for the variant SSCP in this subject (lane 3), the PCR product was cloned into M 13 by blunt end ligation (see Methods). Sequencing of these clones demonstrated that this subject carries a heterozygous transition in codon 583 (GAG -. AAG), which results in the substitution ofthe basic amino acid lysine for the acidic amino acid glutamic acid (Fig. 2) . This mutation occurs in a residue that is conserved in many tyrosine kinases (10, I 1) and lies near the ATP-binding pocket of the c-kit kinase domain (18) . Both the normal and mutated alleles were detected in two independent PCR reactions. Of eight clones sequenced, the mutation was found in five clones and the normal sequence in three. With the exception of the point mutation at codon 583, the DNA sequence determined from these clones was identical to the published sequence for the human c-kit cDNA (4). In addition, although the amino acid sequence ofthis exon is identical in both mouse and human c-kit, species-specific differences in the nucleotide sequence confirmed the human origin of these clones (6) .
Homology of the human phenotype to the W37 mutant mouse. The mutation identified in this piebald subject produces the same amino acid change as the previously described 1 2 3 4 5 6 7 8 9 10 Figure 1 . tions of the sequencing Lys TRP GLU PHE PRO ladder spanning the mutation at nucleotide 1768 for one normal allele and one mutant allele. The normal allele had the same sequence as published for human c-kit (4), and was confirmed in two other clones. The mutant allele had the same sequence as described except at codon 583, which was AAG instead ofGAG, resulting in the substitution of lysine for glutamic acid. The sequence of this clone was confirmed in four other clones from two independent PCR reactions.
W37 mutation in the mouse c-kit gene (10, 1 1, 19) . To compare the phenotype produced by the same mutation in two different species, mice heterozygous for the W37 mutation were obtained from The Jackson Laboratory (Bar Harbor, ME). The heterozygous subject and her almost identically affected son manifest a large white hair forelock and depigmentation which extends from the vertex ofthe head to the root ofthe nose and involves the medial eyebrows and chin. Depigmentation is also extensive on the extremities, ventral abdomen and thorax, and extends to involve both sides ofthe back. In a similar fashion, the heterozygous mouse, which is normally entirely black, exhibits very extensive hypopigmentation, previously estimated at -85% of the coat (20) . The residual pigmentation in the mouse is limited largely to the face, ears, rump, and a few areas on the dorsal surface of the back. One difference between the two species, however, is the more diffuse and apparently random pattern of dorsal pigmentation seen in the mouse homologue, in contrast to the nearly complete sparing of the central back in the human kindred, an almost invariant feature of human piebald trait (1).
Discussion
In this paper we report the detection of a point mutation in the c-kit membrane receptor gene that is associated with the human developmental defect piebald trait. This mutation is nonconservative, resulting in the substitution of a lysine for a glutamic acid in the tyrosine kinase domain of the c-kit gene. Moreover, the mutation is identical to a previously characterized mutation in the mouse c-kit gene which results in a loss of autophosphorylation activity in the protein product in vitro (10, I 1) and a "dominant negative" phenotype with extensive depigmentation in vivo (20) . Because the amino acid sequence ofthis region is completely conserved between mouse and man (4, 6), the human mutation is sufficient to account for the dominant negative phenotype observed clinically and is almost certainly the cause of the piebaldism in this case.
The amino acid residue Glu583, which is replaced by lysine in one allele ofthe c-kit gene in this piebald subject, forms part of a consensus sequence Trp-Glu-X-X-Arg, which is found in all members of the platelet-derived growth factor receptor and insulin receptor subfamilies, and in some members ofthe c-src and c-abl subfamilies of transmembrane receptor tyrosine kinases (10, 1 1) . The loss of autophosphorylation activity associated with this mutation of the mouse c-kit gene presumably results from its location just amino terminal to the ATP-binding consensus sequence, Gly-X-Gly-X-X-Gly, which is found in all protein kinases and is known to be critical for kinase activity (18) . In addition to a loss ofautophosphorylation activity, the mature W37 kit protein appears to be less stable than the wild-type protein product and incapable of association with signaling proteins phospholipase Cy1 and phosphatidylinositol-3kinase (10, 11, 19) . Thus, it seems likely that the homologous human mutation would also interfere with the signal transduction pathway triggered by interaction of the receptor with its ligand. Recently, a mutation in the same consensus sequence, substituting a glutamine for the conserved arginine residue, has been reported to result in decreased activity of the human insulin receptor, a result consistent with a positive function for this domain (21) .
Although the mutation described here results in an unusually extensive pattern of depigmentation, the deletion of one c-kit allele appears to be associated with a more limited defect of pigmentation (9) . Similarly, the homologous mouse W37 mutation produces more depigmentation in heterozygotes (20) than the deletion of a single mouse c-kit allele (22) . To explain the increased effects of this and other dominant negative mutant c-kit receptors (23) , it has been suggested that the transduction of extracellular signals requires oligomerization of receptor molecules in the presence ofligand (24) . Thus, the point mutation described here could cause a dominant negative effect by producing defective or unstable heterodimers with impaired kinase activity, or by binding ligand nonproductively in situations where ligand is limiting. In contrast, mutations which result in loss of expression of a normal protein product would be expected to cause a 50% reduction in receptor number and a relatively limited pigmentation defect. Mutations in other transmembrane receptor tyrosine kinases, such as the epidermal growth factor and insulin receptors (25) (26) (27) , as well as in the thyroid nuclear receptor (28) , have also been associated with dominant negative mechanisms.
An interesting question is why mutations of the c-kit gene leave some areas pigmented and other areas totally unpigmented. One possibility is that the alteration in receptor function impairs migration (29) , proliferation (30), or survival (31) of the neural crest-derived pigment stem cells, resulting in a failure of melanoblast colonization at anatomic sites most distant from the neural crest. Alternatively, melanoblasts migrating into the forehead and other frequently involved areas may be at the low end of a gradient for the c-kit receptor ligand (32, 33) . Recent evidence suggests that after the migration ofneural crest-derived cells, a second phase of receptor-dependent melanocyte proliferation occurs at 14.5 d of mouse gestation in the mesoderm of embryonic skin (34) . The existence of two distinct stages ofc-kit receptor dependence would be consistent with a model in which "null" mutations affect primarily the first phase of primitive neural crest-derived cell migration, resulting in a limited pigmentation defect at specific sites, while Piebald Trait Resultingfrom a Mutant Allele ofthe c-kit Receptor Gene 1715 dominant negative mutations also affect the second phase of melanocyte proliferation, accounting for the more diffuse, almost random pattern of depigmentation seen in these mutant mice. If this model is correct, the more complete preservation of dorsal pigmentation in human piebaldism suggests that melanocyte proliferation occurring within the mesoderm may be less critical or differently regulated in human as opposed to mouse development.
In addition to their effects on pigmentation, dominant negative mutations generally cause a mild macrocytic anemia and hypogonadism in heterozygous mice (20) . In the most extreme case, two abnormal c-kit alleles invariably cause both severe anemia and sterility in homozygous mice (35) . Thus, the function ofthis tyrosine kinase membrane receptor is necessary not only for pigment cell development but also, in the mouse, for hematopoietic stem cells and germ cells as well. While the current studies show a close correspondence between receptor function in the melanocyte development of both species, an essential role for human c-kit in human hematopoiesis and germ cell development has not been demonstrated, although the gene is expressed in human germ cell tumors (36) , and hematopoietic cells (37, 38) . In this regard it is interesting to note that subject D was not anemic (data not shown) and appears to have normal fertility. However, in contrast to other dominant negative mutations of c-kit, the W37 mutation is unusual in its lack of effect on the hematopoietic or germ cell lineages in heterozygous mice (20 (35) . Thus, some cases ofpiebald trait may prove to result from mutations in this gene, rather than in the receptor gene.
Using an approach similar to that described here, we are currently screening exons ofthe c-kit ligand gene for mutations in other piebald subjects.
The present studies strongly suggest that the c-kit mutation described here is the cause ofpiebald trait in one subject. Taken together with the previously reported cases involving a point mutation (8) 
